Response to mTOR and PI3K inhibitors in enzalutamide-resistant luminal androgen receptor triple-negative breast cancer patient-derived xenografts
2018 ◽
Vol 144
(3)
◽
pp. 651-664
◽
2015 ◽
2017 ◽
2019 ◽